Complement-Mediated Hemolytic Uremic Syndrome Due to MCP/CD46 Mutation: A Case Report
Thrombotic microangiopathy (TMA) is a severe condition characterized by microangiopathic hemolytic anemia, thrombocytopenia, and end-organ damage, often involving the kidneys. Complement-mediated hemolytic uremic syndrome (cHUS), a rare form of TMA, arises from dysregulated alternative complement pa...
Saved in:
Main Authors: | Abdul Muhsen Abdeen MD, Jowan Al-Nusair MD, Malik Samardali MD, Mohamed Alshal MD, Amro Al-Astal MD, Zeid Khitan MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Journal of Investigative Medicine High Impact Case Reports |
Online Access: | https://doi.org/10.1177/23247096251316364 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Common spine codes are reimbursed 13% less by Medicaid compared to Medicare, ranging from 46% to 160% by state
by: Adam P. Henderson, BS, et al.
Published: (2025-03-01) -
Anti-Factor H Antibodies in Egyptian Children with Hemolytic Uremic Syndrome
by: Shereen Shawky, et al.
Published: (2021-01-01) -
Hemolytic Uremic Syndrome Associated with Pneumococcal Pneumonia. A Case Report
by: Ariel Efrén Uriarte Méndez, et al.
Published: (2013-06-01) -
Eculizumab Therapy Leads to Rapid Resolution of Thrombocytopenia in Atypical Hemolytic Uremic Syndrome
by: Han-Mou Tsai, et al.
Published: (2014-01-01) -
Monocytes serve as Shiga toxin carriers during the development of hemolytic uremic syndrome
by: Xinlei Sun, et al.
Published: (2025-01-01)